Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
4547:TYO
Kissei Pharmaceutical Co Ltd
4 320,00 JP¥
-1,26%
(-55,00) 1D
1-май, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4547...
Open
4 400 JP¥
High
4 410 JP¥
Low
4 310 JP¥
Mkt. cap
201,06 млд
Avg. vol.
78,42 миң
Volume
165,60 миң
Dividend
2,66%
Quarterly dividend
29 JP¥
Ex dividend date
2026-ж., 30-мар.
P/E ratio
12,80
52-wk high
5 040 JP¥
52-wk low
3 750 JP¥
EPS
337 JP¥
Shares outstanding
46,72 млн
No. of employees
2 миң
News stories
From sources across the web
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include: Difelikefalin Fostamatinib Linzagolix Mitiglinide Remogliflozin etabonate Silodosin Tranilast In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1,78 миң
Founded1946-ж., 9-авг.
HeadquartersMatsumoto, Nagano, Япония
SectorPharmaceutical industry
Websitekissei.co.jp
Last report
2026-ж., 30-янв.
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
26,80 млд/ (24,41 млд est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
22,66 млд
22,19 млд
23,64 млд
26,80 млд
Cost of goods sold
11,71 млд
11,11 млд
12,03 млд
14,50 млд
Cost of revenue
11,71 млд
11,11 млд
12,03 млд
14,50 млд
Research and development expenses
12,89 млд
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-6,70 млд
8,97 млд
20,55 млд
9,15 млд
Operating expense
9,41 млд
8,97 млд
20,55 млд
9,15 млд
Total operating expenses
21,12 млд
20,08 млд
32,59 млд
23,65 млд
Operating income
1,54 млд
2,11 млд
-8,95 млд
3,16 млд
Other non operating income
20,00 млн
16,00 млн
1,00 млн
10,00 млн
EBT including unusual items
4,04 млд
5,75 млд
3,66 млд
4,20 млд
EBT excluding unusual items
1,63 млд
2,80 млд
-8,82 млд
3,52 млд
Income tax expense
916,00 млн
1,23 млд
305,00 млн
915,00 млн
Effective tax rate
22,69%
21,35%
8,33%
21,81%
Other operating expenses
129,00 млн
-
-
-
Net income
3,12 млд
4,52 млд
3,26 млд
3,23 млд
Net profit margin
13,77%
20,36%
13,81%
12,05%
Earnings per share
-
-
-
-
Interest and investment income
121,00 млн
692,00 млн
212,00 млн
614,00 млн
Interest expense
-6,00 млн
-6,00 млн
-7,00 млн
-7,00 млн
Net interest expenses
115,00 млн
686,00 млн
205,00 млн
607,00 млн
Depreciation and amortization charges
3,09 млд
-
-
-
EBITDA
2,69 млд
3,26 млд
-7,82 млд
4,31 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer